134 results
Page 5 of 7
20-F/A
9xiikz2k3x18suxrwl2
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
qlw1oj
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
ijc05c
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
9cqm04ykisw vn
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
1m82gd0ci2t1 rjsl29
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
qov2hf0eu1e d2ig9
5 Mar 15
Current report (foreign)
12:00am
424B2
vmkfmn 20
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1.1
oolodok7ge 1mnjx
30 May 14
Current report (foreign)
12:00am
F-3
p1mer cs1es8bnzx
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
316 fyju86nzd
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
x1x2iifhbmfuo2p
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
jphzut397ub36tqv
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
vfqvu354ra6f29h jovg
3 Mar 14
Current report (foreign)
12:00am
424B3
7ei1w6exk
8 Aug 13
Prospectus supplement
12:00am
424B5
xb1y7h6u15lffnuoc
17 May 13
Prospectus supplement for primary offering
12:00am